NCTracks
New Medicaid Bulletin Articles Available as of Jan. 11
The NC Division of Health Benefits (DHB) has recently published new Medicaid Bulletin articles:
- Pozelimab-bbfg Injection, for Intravenous or Subcutaneous Use (Veopoz™) HCPCS Code J3590 - Unclassified Biologics: Billing Guidelines - Effective with date of service Aug. 19, 2023, NC Medicaid covers pozelimab-bbfg injection, for intravenous or subcutaneous use (Veopoz).
- Cantharidin Topical Solution (Ycanth™) HCPCS code J3490 - Unclassified Drugs: Billing Guidelines - Effective with date of service Sept. 1, 2023, NC Medicaid Direct and NC Medicaid Managed Care cover cantharidin topical solution (Ycanth).
- Avacincaptad Pegol Intravitreal Solution (Izervay™) HCPCS Code J3490 - Unclassified Drugs: Billing Guidelines - Effective with date of service Sept. 6, 2023, NC Medicaid Direct and NC Medicaid Managed Care cover avacincaptad pegol intravitreal solution (Izervay)
- Aflibercept Injection, for Intravitreal Use (Eylea® HD) HCPCS Code J3590 - Unclassified Biologics: Billing Guidelines - Effective with date of service Aug. 21, 2023, Medicaid covers aflibercept injection, for intravitreal use (Eylea HD)
Providers are encouraged to review this information. All bulletin articles, including those related to COVID-19, are available on DHB's Medicaid Bulletin webpage.